HbO2 Therapeutics

The leader in oxygen delivery technologies


(

Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9




Hemoglobin Oxygen Therapeutics: Fast Facts

Hemoglobin Oxygen (HbO2) Therapeutics is the leader in oxygen delivery therapeutics, which were developed to mimic the red blood cell function of oxygen delivery to tissues and organs, while being room temperature stable for three years and not requiring blood typing or matching


Major Problem

When people are in need of medical care, medical professionals may run into the following problems:


Groundbreaking Solution

HbO2 Therapeutics solves these problems by:


Why We’ll Lead

Our forte, hemoglobin oxygen base carriers, have same oxygen-carrying capacity as whole blood. Equally as important is the fact that no blood type or matching is required.

Sterile and offering a three-year shelf life, our solution is helpful for blood transfusions. And because of the chemical makeup, the molecule of our products is about 1Mx smaller than red blood cells.

There are many uses for an oxygen carrier, but he main point of market entry would be human and veterinary transfusions.


Traction & Accomplishments 

In addition to our outstanding leadership team, HbO2 Therapeutics has also formed collaborative agreements and research partnerships with well over 100 large hospitals, academic institutions, all branches of the military branches, and more.

Our expanded access program hospitals include:

Our major academic and health centers collaborations include:


Meet The Team

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.


Request Access

N

No updates yet.




%

No backers yet.




Quick Signup TBD

You must have an account to do this!


the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.